U.S. opioid crackdown hampers some patients' access to psychiatric drugs

Posted on AllSides December 12th, 2022
From The Center
REUTERS/Russell Boyce/Illustration

A crackdown by U.S. drug wholesalers in response to the opioid crisis is preventing some pharmacists from dispensing a combination of stimulants and sedatives routinely prescribed by psychiatrists to help patients manage conditions like anxiety and ADHD.

The three main U.S. pharmaceutical wholesalers - AmerisourceBergen Corp (ABC.N), Cardinal Health Inc (CAH.N) and McKesson Corp (MCK.N) - tightened monitoring of suspicious orders from pharmacies in July as part of a $21 billion nationwide opioid settlement with attorneys general from 46 states, the District of Columbia, and five territories.

Five independent pharmacists in five different U.S. states told Reuters...

Read full story

Reuters

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
You agree.
Thank you! Community votes alone don't determine our ratings, but are valuable feedback and can prompt us to do more research.
124085/93184
See full bias rating for Reuters
Learn about media bias

AllSides Picks

https://www.reuters.com/business/healthcare-pharmaceuticals/us-opioid-crackdown-hits-some-patients-access-psychiatric-drugs-2022-12-12/

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right